antisens
drug
oblimersen
sodium
genta
inc
phosphorothio
oligodeoxynucleotid
odn
contain
unmethyl
cpg
unit
target
suppress
expect
reduct
level
would
facilit
apoptosi
drugresist
cancer
cell
last
sever
year
evalu
sever
phase
iii
cancer
clinic
trial
unfortun
slightli
improv
perform
classic
chemotherapeut
agent
hypothes
disappoint
part
due
fact
cancer
clone
lost
activ
intern
stress
variou
sort
metabol
physic
genotox
commun
via
independ
signal
pathway
integr
singl
level
cellular
stress
activ
slow
cell
cycl
delay
cell
cycl
allow
cellular
stress
mitig
eg
dna
repair
restor
ph
eh
nutrient
level
metabol
excret
toxin
activ
reach
level
summon
proapoptot
protein
eg
bax
bak
initi
apoptosi
finetun
threshold
stress
apoptosi
occur
block
action
proapoptot
protein
fig
pathway
appar
absent
major
cancer
clone
shown
util
gene
therapi
eg
advexin
r
introgen
therapeut
inc
thu
suppress
combin
classic
chemotherapi
induc
intern
stress
eg
genotox
much
posit
effect
apoptosi
abnorm
cell
hand
would
appear
combin
drug
restor
activ
ii
suppress
iii
induc
intern
stress
cancer
cell
iv
suppress
cell
fusion
would
attract
candid
clinic
trial
anoth
possibl
reason
littl
benefit
cancer
clinic
trial
fact
work
suspend
cell
cycl
via
cancer
may
inhibit
remain
block
uncontrol
cell
cycl
obvious
case
suppress
would
undesir
unless
led
immedi
apoptosi
final
anoth
import
featur
name
unmethyl
cpg
compound
extens
test
clinic
trial
unmethyl
cpg
compound
known
stimul
immun
respons
activ
leucocyt
would
appear
desir
anticanc
effect
may
inde
account
benefit
preclin
studi
shown
fig
actual
play
import
role
induc
apoptosi
trigger
extern
death
signal
specif
bind
fa
cell
surfac
fasl
tnf
etc
activ
cleav
proapoptot
baxlik
fragment
iron
suppress
benefit
enhanc
immun
respons
extern
stress
tumor
appear
larg
lost
inde
effect
appear
lead
signific
advers
toxic
cancer
trial
shown
suppress
tcell
bcell
monocyt
combin
activ
immun
cell
block
express
lead
substanti
apoptosi
neutropenia
thrombocytopenia
seem
clear
effect
cell
becom
infect
hiv
probabl
undesir
treat
individu
low
level
tcell
howev
tcell
level
stabil
haart
may
well
activ
transcript
latent
hiv
proviru
induc
intern
stress
infect
tcell
present
uninfect
bystand
tcell
overexpress
essenti
surviv
hivinfect
cell
activ
transcrib
proviru
henc
without
benefit
elev
activ
hivinfect
tcell
preferenti
undergo
apoptosi
time
lower
level
bystand
tcell
make
less
suscept
extern
death
signal
thu
suppress
concurr
protect
uninfect
cell
ravag
hivinfect
tcell
hypothesi
origin
publish
knowledg
one
mean
test
given
seriou
consider
result
clinic
trial
greatli
reduc
enthusiasm
anticanc
drug
report
success
elimin
ebv
nasopharyng
carcinoma
xenograft
scid
mice
suggest
drug
elimin
barrier
viral
intern
stress
induc
apoptosi
turn
hiv
suppress
cellular
well
caus
overexpress
cellular
step
restor
function
might
necessari
